Patents by Inventor Wanying Lu

Wanying Lu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240254469
    Abstract: The present invention provides a hybrid antimicrobial protein having a strong bactericidal effect and an application thereof. Said hybrid antimicrobial protein having a strong bactericidal effect is a hybrid protein with the amino acid sequence of SEQ ID NO: 1 which named AB469; or a hybrid protein including a sequence similar to a catalytic domain of the AB469, or a hybrid protein including a sequence similar to a binding domain of the AB469; or, a hybrid protein including the catalytic and binding domains with positions interchanged of the AB469.
    Type: Application
    Filed: September 22, 2020
    Publication date: August 1, 2024
    Applicant: Jiangxi Yuansheng Biological Technology Co., Ltd.
    Inventors: Hairong LU, Qingshan HUANG, Guodong LI, Jinjiang HUANG, Xiaowei ZHAO, Wanying LU
  • Patent number: 8241901
    Abstract: A method of secretory expression of lysostaphin in Escherichia coli at high level, which comprises constructing a expression vector by cloning a sequence encoding a signal peptide which is suitable for secretory expression in Escherichia coli before part or whole gene sequence which encodes mature lysostaphin, and ligating the cloned sequence with a promoter; and transforming Escherichia coli with the expression vector, culturing and fermenting, and then isolating lysostaphin from the supernatant of the fermentation broth. The advantage of secretory expression is that the expression product can exist in the medium in an active form, and thus does not need the process for renaturation of the inclusion body; it is more easily to purify from the supernatant of the fermentation broth with high rate of recovery; and there is less contamination from the host's proteins.
    Type: Grant
    Filed: July 11, 2006
    Date of Patent: August 14, 2012
    Assignee: Shanghai Hi-Tech United Bio-Technological Research & Development Co., Ltd.
    Inventors: Qingshan Huang, Hairong Lu, Wanying Lu
  • Publication number: 20090186380
    Abstract: A method of secretory expression of lysostaphin in Escherichia coli at high level, which comprises constructing a expression vector by cloning a sequence encoding a signal peptide which is suitable for secretory expression in Escherichia coli before part or whole gene sequence which encodes mature lysostaphin, and ligating the cloned sequence with a promoter; and transforming Escherichia coli with the expression vector, culturing and fermenting, and then isolating lysostaphin from the supernatant of the fermentation broth. The advantage of secretory expression is that the expression product can exist in the medium in an active form, and thus does not need the process for renaturation of the inclusion body; it is more easily to purify from the supernatant of the fermentation broth with high rate of recovery; and there is less contamination from the host's proteins.
    Type: Application
    Filed: July 11, 2006
    Publication date: July 23, 2009
    Applicant: Shanghai Hi-Tech United Bio-Technological Research & Development Co., Ltd.
    Inventors: Qingshan Huang, Hairong Lu, Wanying Lu